Repsol starts producing its new metallocene polyethylene range
After becoming the first license of Chevron Phillips Chemical’s proprietary technology for production of metallocene-based polyethylene resins, Repsol has implemented this innovative technology at its plant in Tarragona, Spain. This is a great endeavour due to the fact that this is a swing plant capable of producing both metallocene linear low density polyethylene (mLLDPE) and high density polyethylene (HDPE).
Repsol has completed this project and run the first tests with success. The whole process has been completed on time and with zero incidents regarding the safety of people, facilities and the environment.
This new range of metallocene-based polyethylene grades, Repsol Resistex®, offers higher-value end-products that confirm Repsol’s focus on product differentiation and specialties. With the launch of this new range, Repsol furthers its commitment to its European polyethylene customers.
Categories
Investments
Chemical substances
Countries
Companies
Latest news
INEOS launches €250m investment supported by the French Government to secure the future of French industry at Lavera
The project marks the first phase of a long-term regeneration plan to reduce emissions, boost reliability, efficiency and competitiveness, with support of the French State.
Hycamite’s technology to decarbonize shipping awarded AiP by industry leader DNV
Kokkola Industrial Park →Hycamite’s proprietary Thermo-Catalytic Decomposition (TCD) technology offers a new approach to producing clean hydrogen by breaking down methane, the primary component of liquefied natural gas (LN...
Clariant catalysts will power the Ecoplanta: Europe's first waste-to-methanol plant
Chemmed Cluster Tarragona →Repsol is building Europe’s first plant to produce renewable methanol from urban waste The facility will use Enerkem gasification technology to produce 240 KTA of methanol Clariant will supply cata...
Lilly plans to build a new $3 billion facility to boost oral medicine manufacturing capacity in Europe for patients worldwide
Netherlands site will bring 500 manufacturing and 1,500 construction jobs while further strengthening Lilly's global supply chain
